Immune checkpoint inhibitors (ICIs) activate anti-cancer immunity by blocking T cell
checkpoint molecules such as programmed death 1 (PD-1) and cytotoxic T lymphocyte …

Abstract Purpose of Review To examine the epidemiological data on obesity and leukemia;
evaluate the effect of obesity on leukemia outcomes in childhood acute lymphoblastic …

B cell malignancies, comprising over 80 heterogeneous blood cancers, pose significant
prognostic challenges due to intricate oncogenic signaling. Emerging evidence emphasizes …

Galectin-9 (Gal-9) is a vital member of the galectin family, functioning as a multi-subtype
galactose lectin with diverse biological roles. Recent research has revealed that Gal-9's …

Galectin-1 is a carbohydrate-binding protein expressed in many tissues. In recent years,
increasing evidence has emerged for the role of galectin-1 in obesity, insulin resistance and …

Galectin-9 (Gal-9) is a tandem-repeat galectin with diverse roles in immune homeostasis,
inflammation, malignancy, and autoimmune diseases. In cancer, Gal-9 displays variable …

Immunochemotherapy has become popular in recent years. The detailed mechanisms of
cancer immunity are being elucidated, and new developments are expected in the future …

Obesity is a global pandemic and public health crisis over decades. Except for physical
activity, dietary adjustments, pharmacotherapy and surgical interventions, prebiotics, which …

Optimizations are expected in the development of immunotherapy for the treatment of Triple‐
negative breast cancer (TNBC). We studied the expression of galectin‐9 (Gal‐9) after …

Various socioeconomic and biologic factors affect cancer health disparities and differences
in health outcomes. To better characterize the socioeconomic vs biologic determinants of …